title: S1 guideline diagnosis and therapy of cutaneous larva migrans (creeping disease).
abstract: These guidelines aim to enhance patient care by optimizing the diagnosis and treatment of infections due to creeping disease (cutaneous larva migrans) and to raise awareness among doctors of current treatment options.
  
  
  METHODS
  S1 guideline, non-systematic literature search, consensus process using a circular letter.
authors.affiliation: Department of Dermatology and Venereology - Münster University Hospital, Germany.
authors.forename: Cord
authors.initials: C
authors.lastname: Sunderkötter
authors.forename: Esther
authors.initials: E
authors.lastname: von Stebut
authors.forename: Helmut
authors.initials: H
authors.lastname: Schöfer
authors.forename: Martin
authors.initials: M
authors.lastname: Mempel
authors.forename: Dieter
authors.initials: D
authors.lastname: Reinel
authors.forename: Gerd
authors.initials: G
authors.lastname: Wolf
authors.forename: Volker
authors.initials: V
authors.lastname: Meyer
authors.forename: Alexander
authors.initials: A
authors.lastname: Nast
authors.forename: Gerd-Dieter
authors.initials: GD
authors.lastname: Burchard
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D015766:Albendazole / Q000008:administration & dosage*; D000969:Antinematodal Agents / Q000008:administration & dosage*; D003880:Dermatology / Q000592:standards*; D004305:Dose-Response Relationship, Drug; D005858:Germany; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage*; D007815:Larva Migrans / Q000175:diagnosis* / Q000188:drug therapy* / Q000469:parasitology / Q000473:pathology; D017410:Practice Guidelines as Topic
chemical_list: D000969:Antinematodal Agents; D007559:Ivermectin; D015766:Albendazole